Qilian International Holding Group Ltd. Class A Ordinary Shares (BGM)

Market Cap: $45.7M

About: Qilian International Holding Group Ltd is a pharmaceutical and chemical company. The company is engaged in the development, manufacture, marketing, and sale of licorice products, oxytetracycline products, traditional Chinese medicine derivatives products, heparin products, sausage casings, and fertilizers. It operates through three segments namely, Oxytetracycline and Licorice products and TCMD; Fertilizer; and Heparin products and Sausage casing. Oxytetracycline and Licorice products and TCMD segment generates majority of the revenue.

Employees: 298

Fund manager confidence

Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

26% less capital invested

Capital invested by funds: $25.7K [Q1] → $18.9K (-$6.72K) [Q2]

50% less funds holding

Funds holding: 4 [Q1] → 2 (-2) [Q2]

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 2